FDA Adverse Event Malfunction Summary report: N

ANIMAS VIBE SYSTEM

MDR report key: 7470064 · Received April 27, 2018

Report

Report Number
3004753838-2018-044972
Event Type
Malfunction
Date Received
April 27, 2018
Date of Event
April 6, 2018
Report Date
April 6, 2018
Manufacturer
DEXCOM, INC.
Product Code
OYC
UDI-DI
00386270000125
PMA / PMN Number
P130007
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVENT OR PROBLEM DESCRIPTION - ADDITIONAL INFORMATION. DEVICE PRODUCT CODE - CORRECTION TO OYC. DATE RECEIVED BY MANUFACTURER - ADDITIONAL INFORMATION. CORRECTION, ADDITIONAL INFORMATION, DEVICE EVALUATION. DEVICE EVALUATED, EVALUATION SUMMARY ATTACHED. METHOD CODES - ADD 10, 38, 3329; REMOVE 3263, 3331 - ADDITIONAL INFORMATION/CORRECTION. RESULT CODES - ADD 213; REMOVE 3233 - ADDITIONAL INFORMATION. CONCLUSION CODES - ADD 94; REMOVE 11 - ADDITIONAL INFORMATION. CORRECTED DATA.

Additional Manufacturer Narrative · 1

(B)(4). THE PATIENT EXPERIENCED ADVERSE EVENTS ON DIFFERENT DAYS WITH THE SAME DEVICE. THE FOLLOWING REPORTS ARE BEING SUBMITTED: (B)(4).

Description of Event or Problem · 1

THE COMPLAINT DEVICE WAS RETURNED FOR EVALUATION. THE DEVICE WAS VISUALLY INSPECTED, AND NO DEFECT WAS FOUND. VOLTAGE TESTING WAS PERFORMED AND FAILED. A REVIEW OF THE DATA LOG WAS NOT PERFORMED AS THERE WAS NO DATA AVAILABLE. CONFIRMATION OF THE ISSUE WAS UNDETERMINED.

Description of Event or Problem · 1

DEXCOM WAS MADE AWARE ON (B)(4) 2018, THAT ON (B)(6) 2018, A LOSS OF CONNECTION OCCURRED. PRODUCT HAS BEEN RECEIVED FOR INVESTIGATION. A FOLLOW-UP WILL BE SUBMITTED UPON COMPLETION OF DEVICE INVESTIGATION. CONFIRMATION OF THE ISSUE WAS UNDETERMINED. THE PROBABLE CAUSE COULD NOT BE DETERMINED. NO ADDITIONAL PATIENT OR EVENT INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
310463 ANIMAS VIBE SYSTEM CONTINUOUS GLUCOSE MONITOR OYC DEXCOM, INC. 9438-05 5231965 00386270000125

Patients

Seq Age Sex Outcome Treatment
1 25 YR